Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Graillot

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Investigational New Drugs|July 31, 2016
Sunitinib-induced sudden hearing lossKathleen Dekeister, Emmanuelle Graillot, Mickaël Durbec, et al.
Scientific Reports|January 12, 2017
Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markersPatricia Freis, Emmanuelle Graillot, Pascal Rousset, et al.
Endocrine-Related Cancer|December 15, 2016
Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelinesMargaux Foulfoin, Emmanuelle Graillot, Mustapha Adham, et al.
Endocrine|November 19, 2017
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter studyDavide Campana, Thomas Walter, Sara Pusceddu, et al.
Journal of Geriatric Oncology|April 25, 2018
An onco-geriatric approach to select older patients for optimal treatments of pancreatic adenocarcinomaElisabeth Castel-Kremer, Solene De Talhouet, Anne-Laure Charlois, et al.
Gastroenterologie Clinique Et Biologique|May 25, 2010
Lethal acute HEV superinfection on hepatitis B cirrhosisAnne-Marie Marion-Audibert, Sophie Tesse, Emmanuelle Graillot, et al.
Endoscopy|April 12, 2017
Adenoma detection with blue-water infusion colonoscopy: a randomized trialAdriane Lesne, Olivier Rouquette, Sandrine Touzet, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Investigational New Drugs|July 31, 2016
Sunitinib-induced sudden hearing lossKathleen Dekeister, Emmanuelle Graillot, Mickaël Durbec, et al.
Scientific Reports|January 12, 2017
Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markersPatricia Freis, Emmanuelle Graillot, Pascal Rousset, et al.
Endocrine-Related Cancer|December 15, 2016
Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelinesMargaux Foulfoin, Emmanuelle Graillot, Mustapha Adham, et al.
Endocrine|November 19, 2017
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter studyDavide Campana, Thomas Walter, Sara Pusceddu, et al.
Journal of Geriatric Oncology|April 25, 2018
An onco-geriatric approach to select older patients for optimal treatments of pancreatic adenocarcinomaElisabeth Castel-Kremer, Solene De Talhouet, Anne-Laure Charlois, et al.
Gastroenterologie Clinique Et Biologique|May 25, 2010
Lethal acute HEV superinfection on hepatitis B cirrhosisAnne-Marie Marion-Audibert, Sophie Tesse, Emmanuelle Graillot, et al.
Endoscopy|April 12, 2017
Adenoma detection with blue-water infusion colonoscopy: a randomized trialAdriane Lesne, Olivier Rouquette, Sandrine Touzet, et al.
Pageof 1